Annual Accounts Receivable
$53.87 M
+$10.79 M+25.04%
December 31, 2023
Summary
- As of February 7, 2025, MDXG annual accounts receivable is $53.87 million, with the most recent change of +$10.79 million (+25.04%) on December 31, 2023.
- During the last 3 years, MDXG annual accounts receivable has risen by +$18.45 million (+52.08%).
- MDXG annual accounts receivable is now -19.78% below its all-time high of $67.15 million, reached on December 31, 2016.
Performance
MDXG Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$54.03 M
+$1.23 M+2.33%
September 30, 2024
Summary
- As of February 7, 2025, MDXG quarterly accounts receivable is $54.03 million, with the most recent change of +$1.23 million (+2.33%) on September 30, 2024.
- Over the past year, MDXG quarterly accounts receivable has dropped by -$2.99 million (-5.24%).
- MDXG quarterly accounts receivable is now -19.54% below its all-time high of $67.15 million, reached on December 31, 2016.
Performance
MDXG Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
MDXG Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.0% | -5.2% |
| 3 y3 years | +52.1% | +43.4% |
| 5 y5 years | +100.0% | +67.1% |
MDXG Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.5% | -5.2% | +43.5% |
| 5 y | 5-year | at high | +66.6% | -5.2% | +79.5% |
| alltime | all time | -19.8% | -100.0% | -19.5% | -100.0% |
MiMedx Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $54.03 M(+2.3%) |
| Jun 2024 | - | $52.80 M(-7.4%) |
| Mar 2024 | - | $57.02 M(+5.8%) |
| Dec 2023 | $53.87 M(+25.0%) | $53.87 M(+9.9%) |
| Sep 2023 | - | $49.01 M(+0.1%) |
| Jun 2023 | - | $48.96 M(+9.6%) |
| Mar 2023 | - | $44.69 M(+3.7%) |
| Dec 2022 | $43.08 M(+6.8%) | $43.08 M(+5.5%) |
| Sep 2022 | - | $40.83 M(+8.4%) |
| Jun 2022 | - | $37.66 M(-0.0%) |
| Mar 2022 | - | $37.67 M(-6.6%) |
| Dec 2021 | $40.35 M(+13.9%) | $40.35 M(+10.4%) |
| Sep 2021 | - | $36.54 M(-1.9%) |
| Jun 2021 | - | $37.24 M(+5.1%) |
| Mar 2021 | - | $35.42 M(-0.0%) |
| Dec 2020 | $35.42 M(+9.6%) | $35.42 M(+7.2%) |
| Sep 2020 | - | $33.04 M(+9.8%) |
| Jun 2020 | - | $30.10 M(-5.7%) |
| Mar 2020 | - | $31.93 M(-1.2%) |
| Dec 2019 | $32.33 M(>+9900.0%) | $32.33 M(+51.1%) |
| Sep 2019 | - | $21.39 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2017 | - | $59.58 M(-1.9%) |
| Jun 2017 | - | $60.74 M(-9.1%) |
| Mar 2017 | - | $66.85 M(-0.5%) |
| Dec 2016 | $67.15 M(+24.9%) | $67.15 M(+5.9%) |
| Sep 2016 | - | $63.43 M(+15.6%) |
| Jun 2016 | - | $54.86 M(+1.8%) |
| Mar 2016 | - | $53.88 M(+0.2%) |
| Dec 2015 | $53.76 M | $53.76 M(+14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $46.78 M(+18.6%) |
| Jun 2015 | - | $39.45 M(+27.2%) |
| Mar 2015 | - | $31.00 M(+16.2%) |
| Dec 2014 | $26.67 M(+65.7%) | $26.67 M(+14.4%) |
| Sep 2014 | - | $23.30 M(+13.7%) |
| Jun 2014 | - | $20.50 M(+8.1%) |
| Mar 2014 | - | $18.97 M(+17.9%) |
| Dec 2013 | $16.09 M(+110.3%) | $16.09 M(+17.4%) |
| Sep 2013 | - | $13.71 M(+16.5%) |
| Jun 2013 | - | $11.76 M(+19.8%) |
| Mar 2013 | - | $9.82 M(+28.3%) |
| Dec 2012 | $7.65 M(+304.5%) | $7.65 M(+24.0%) |
| Sep 2012 | - | $6.17 M(+56.4%) |
| Jun 2012 | - | $3.95 M(+38.3%) |
| Mar 2012 | - | $2.85 M(+50.8%) |
| Dec 2011 | $1.89 M(+1065.0%) | $1.89 M(+26.0%) |
| Sep 2011 | - | $1.50 M(+23.8%) |
| Jun 2011 | - | $1.21 M(+141.0%) |
| Mar 2011 | - | $503.20 K(+209.9%) |
| Dec 2010 | $162.40 K(>+9900.0%) | $162.40 K(-37.4%) |
| Sep 2010 | - | $259.50 K(-31.8%) |
| Jun 2010 | - | $380.60 K(+229.0%) |
| Mar 2010 | - | $115.70 K(-98.1%) |
| Dec 2009 | $0.00 | - |
| Sep 2009 | - | $6.14 M(-10.8%) |
| Jun 2009 | - | $6.89 M(-11.4%) |
| Mar 2009 | - | $7.77 M(-0.6%) |
| Dec 2008 | - | $7.82 M(-30.5%) |
| Sep 2008 | - | $11.24 M(+9.4%) |
| Jun 2008 | - | $10.28 M(+15.6%) |
| Dec 2007 | - | $8.88 M |
FAQ
- What is MiMedx annual accounts receivable?
- What is the all time high annual accounts receivable for MiMedx?
- What is MiMedx annual accounts receivable year-on-year change?
- What is MiMedx quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for MiMedx?
- What is MiMedx quarterly accounts receivable year-on-year change?
What is MiMedx annual accounts receivable?
The current annual accounts receivable of MDXG is $53.87 M
What is the all time high annual accounts receivable for MiMedx?
MiMedx all-time high annual accounts receivable is $67.15 M
What is MiMedx annual accounts receivable year-on-year change?
Over the past year, MDXG annual accounts receivable has changed by +$10.79 M (+25.04%)
What is MiMedx quarterly accounts receivable?
The current quarterly accounts receivable of MDXG is $54.03 M
What is the all time high quarterly accounts receivable for MiMedx?
MiMedx all-time high quarterly accounts receivable is $67.15 M
What is MiMedx quarterly accounts receivable year-on-year change?
Over the past year, MDXG quarterly accounts receivable has changed by -$2.99 M (-5.24%)